Answers are grounded in this paper and cite their sources.
In the present study, three kinds of curcuminoids (CS)-loaded micelles (CS-NPGS) were prepared by the solid dispersion method using novel Nitogenin polyethylene glycol succinate-1000 (NPGS-1000) to enhance the solubility and bioavailability. The micelles were characterized using a particle size analyzer, a crystallography analyzer, and Fourier transform infrared spectroscopy (FT–IR). The morphology was screened using a scanning electron microscope. In vitro release profiles of curcumin from CS-NPGS showed a sustained release without rapid burst. Treating triple negative MDA-MB-231 cell lines with all micelles remarkably exhibited dose-dependent toxicity and inhibited the cell proliferation. Epifluorescence was used to evaluate the morphology of the treated cells by using various stains. The IC50 values of the curcumin-loaded micelles against triple negative MDA-MB-231 cells were 10.85, 5.43, and 5.43 μg/mL for CS-NPGS-1, CS-NPGS-2, and CS-NPGS-3, respectively, lower than the one of free curcumin (21.7 μg/mL). An in vivo rat oral pharmacokinetic study showed 13.25×, 16.43×, and 18.51× increases in Cmax for CS-NPGS-1, CS-NPGS-2, and CS-NPGS-3 compared to curcuminoid powder, respectively. The relative bioavailability of CS-NPGS-1, CS-NPGS-2, and CS-NPGS-3 was 155.21%, 504.82%, and 687.83% compared to CS, respectively. The aqueous solubility of encapsulated CS-NPGS micelles is considerably improved, allowing for more localized drug delivery and a superior treatment alternative for residual cancer tumors.
No takes yet. Share an insight, caveat, or question.
Shanmugham et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: